Deacetoxyvinzolidine

Star0

DB02868ExperimentalSmall molecule

Deacetoxyvinzolidine: Overview.

Formula / weight: C₄₆H₅₆ClN₅O₇ · 826.419 g/mol (avg)
Code names: KAR-2

Resolves to

Compound

UNII6PBV11IO5ECAS165659-77-8PubChem157684

Structure

InChIKeyNUXKIZBEPYVRKP-RWBWKAGLSA-NSMILES

[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)(C[C@@]22OC(=O)N(CCCl)C2=O)[C@@]13[H])[C@]1(C[C@H]2CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Deacetoxyvinzolidine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account